PD -1/PD-L1 monoclonal antibody plus radiotherapy and liver transplantation
2025-SR-1173
Phase 2 other active
Quick answer
PD -1/PD-L1 monoclonal antibody plus radiotherapy and liver transplantation for Locally Advanced Perihilar Cholangiocarcinoma is a Phase 2 program (other) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Locally Advanced Perihilar Cholangiocarcinoma
- Phase
- Phase 2
- Modality
- other
- Status
- active